质母细胞瘤血管可塑性限制了T细胞透,并被cAMP激活阻止
Zixi Qin1, Youwei Huang2, Zeying Li3
1Department of Pharmacology, School of Medicine, Jinan University, Guangzhou, P.R. China.
Cancer immunology research
|August 4, 2023
概括
用循环腺单酸盐 (cAMP) 激活剂准质瘤衍生性内皮细胞 (GdEC) 可以克服质母细胞瘤.
科学领域:
- 神经瘤学神经瘤学
- 癌症免疫学 癌症免疫学
- 血管生物学 血管生物学
背景情况:
- 质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑癌.
- 像免疫检查点封锁这样的标准免疫疗法在GBM中表现出有限的疗效.
- GBM 呈现出高度血管性和免疫抑制性瘤微环境.
研究的目的:
- 研究质瘤衍生的内皮细胞 (GdECs) 在GBM免疫抑制中的作用.
- 确定针对GdEC的治疗策略,以提高免疫疗法的疗效.
- 探索循环腺单酸盐 (cAMP) 激活剂在GBM治疗中的潜力.
主要方法:
- 建立了用于GdEC分化和药物查的体外模型.
- 使用cAMP激活器来阻止GdEC的形成和分化.
- 在体内评估了cAMP激活剂对瘤血管和免疫细胞透的影响.
- 评估了GdEC阻断和PD-1抑制的联合治疗.
主要成果:
- GdECs的基因组特征与免疫抑制和质瘤预后不佳相关.
- cAMP激活剂通过氧化应激有效地抑制GdEC的形成.
- 在体内,cAMP激活剂使瘤血管正常化,并增加了CD8+ T细胞的透和功能.
- 结合GdEC阻塞和PD-1抑制导致瘤回归和免疫记忆.
结论:
- 在GBM中,内皮转基因分化会产生免疫屏障.
- 用cAMP激活剂向GdEC可以使GBM重新敏感于免疫疗法.
- 结合GdEC阻断和免疫疗法的联合疗法对GBM治疗具有前景.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


